Clinical Practice Guideline: Management of Acute Coronary Syndrome

Organization: American College of Cardiology
Publication Date: 2023-09-10
Version: 2023.1

Recommendations:

Class I (Strong Recommendation):
1. Dual antiplatelet therapy for all ACS patients
2. Early invasive strategy within 24 hours for high-risk patients
3. Statin therapy initiated within 24 hours

Class IIa (Moderate Recommendation):
1. Beta-blocker therapy within 24 hours if no contraindications
2. ACE inhibitor therapy for patients with reduced ejection fraction

Class III (Not Recommended):
1. Routine use of glycoprotein IIb/IIIa inhibitors
2. Prophylactic antiarrhythmic therapy

Evidence Level: Based on multiple randomized controlled trials and 
meta-analyses involving over 50,000 patients.